Cerebrospinal fluid levels of S-100β in children and its elevation in pediatric meningitis

Pediatric Critical Care Medicine

Volumn 5, Issue 1, 2004, Pages 53-57

  Spinella, Philip C ^a   Donoghue, Aaron ^a   Rajendra, Anil ^a   Drott, Henry R ^a   Dominguez, Troy E ^a   Helfaer, Mark ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

Cerebrospinal fluid; Children; Meningitis; S 100 protein

Indexed keywords

NERVE GROWTH FACTOR; PROTEIN S 100; S 100 CALCIUM BINDING PROTEIN BETA SUBUNIT; S-100 CALCIUM-BINDING PROTEIN BETA SUBUNIT;

ADOLESCENT; ARTICLE; CASE CONTROL STUDY; CEREBROSPINAL FLUID; CHILD; COHORT ANALYSIS; FEMALE; HUMAN; INFANT; MALE; MENINGITIS; METABOLISM; MULTIVARIATE ANALYSIS; NEWBORN; NONPARAMETRIC TEST; PRESCHOOL CHILD; REGRESSION ANALYSIS;

ADOLESCENT; CASE-CONTROL STUDIES; CEREBROSPINAL FLUID; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MENINGITIS; MULTIVARIATE ANALYSIS; NERVE GROWTH FACTORS; REGRESSION ANALYSIS; S100 PROTEINS; STATISTICS, NONPARAMETRIC;

EID: 2142758222     PISSN: 15297535     EISSN: 19473893     Source Type: Journal    
DOI: 10.1097/01.PCC.0000102221.98378.7D     Document Type: Article

References (35)

1. Heizmann CW, Fritz G, Schafer BW: S100 proteins: Structure, functions and pathology. Front Biosci 2002; 7:d1356-d1368
2. Gazzolo D, Bruschettini M, Lituania M, et al: Increased urinary S100B protein as an early indicator of intraventricular hemorrhage in preterm infants: Correlation with the grade of hemorrhage. Clin Chem 2001; 47: 1836-1838
3. Donato R: S100: A multigenic family of calcium- modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int J Biochem Cell Biol 2001; 33:637-668
4. Berger RP, Pierce MC, Wisniewski SR, et al: Neuron-specific enolase and S100B in cerebrospinal fluid after severe traumatic brain injury in infants and children. Pediatrics 2002; 109:E31
5. van Engelen BG, Lamers KJ, Gabreels FJ, et al: Age-related changes of neuron-specific enolase, S-100 protein, and myelin basic protein concentrations in cerebrospinal fluid. Clin Chem 1992; 38:813-816
6. Nygaard O, Langbakk B, Romner B: Age- and sex-related changes of S-100 protein concentrations in cerebrospinal fluid and serum in patients with no previous history of neurological disorder. Clin Chem 1997; 43: 541-543
7. Mokuno K, Kato K, Kawai K, et al: Neuronspecific enolase and S-100 protein levels in cerebrospinal fluid of patients with various neurological diseases. J Neurol Sci 1983; 60: 443-451
8. Mokuno K, Kiyosawa K, Sugimura K, et al: Prognostic value of cerebrospinal fluid neuron- specific enolase and S-100b protein in Guillain-Barr syndrome. Acta Neurol Scand 1994; 89:27-30
9. Infante JR, Torres-Avisbal M, Martinez A, et al: Evaluation of tumor marker S-100 in cerebrospinal fluid from subjects with nonischemic brain pathologies. Tumour Biol 2000; 21:38-45
10. Peskind ER, Griffin WS, Akama KT, et al: Cerebrospinal fluid S100B is elevated in the earlier stages of Alzheimer's disease. Neurochem Int 2001; 39:409-413
11. Pemberton LA, Brew BJ: Cerebrospinal fluid S-100beta and its relationship with AIDS dementia complex. J Clin Virol 2001; 22: 249-253
12. Oski F. Principles and Practice of Pediatrics. Second Edition. Philadelphia, JB Lippincott, 1994, p 2169
13. Fiser DH: Assessing the outcome of pediatric intensive care. J Pediatr 1992; 121:68-74
14. Fiser DH, Long N, Roberson PK, et al: Relationship of pediatric overall performance category and pediatric cerebral performance category scores at pediatric intensive care unit discharge with outcome measures collected at hospital discharge and 1- and 6-month follow-up assessments. Crit Care Med 2000; 28:2616-2620
15. Fiser DH, Tilford JM, Roberson PK: Relationship of illness severity and length of stay to functional outcomes in the pediatric intensive care unit: A multi-institutional study. Crit Care Med 2000; 28:1173-1179
16. Noppe M, Crols R, Andries D, et al: Determination in human cerebrospinal fluid of glial fibrillary acidic protein, S-100 and myelin basic protein as indices of non-specific or specific central nervous tissue pathology. Clin Chim Acta 1986; 155:143-150
17. Merkelbach S, Rohn S, Konig J, et al: Usefulness of clinical scores to predict outcome in bacterial meningitis. Infection 1999; 27: 239-243
18. Klinger G, Chin CN, Otsubo H, et al: Prognostic value of EEG in neonatal bacterial meningitis. Pediatr Neurol 2001; 24:28-31
19. Spranger M, Schwab S, Krempien S, et al: Excess glutamate levels in the cerebrospinal fluid predict clinical outcome of bacterial meningitis. Arch Neurol 1996; 53:992-996
20. Madagame ET, Havens PL, Bresnahan JM, et al: Survival and functional outcome of children requiring mechanical ventilation during therapy for acute bacterial meningitis. Crit Care Med 1995; 23:1279-1283
21. Kornelisse RF, Westerbeek CM, Spoor AB, et al: Pneumococcal meningitis in children: Prognostic indicators and outcome. Clin Infect Dis 1995; 21:1390-1397
22. Hoen B, Viel JF, Gerard A, et al: Mortality in pneumococcal meningitis: A multivariate analysis of prognostic factors. Eur J Med 1993; 2:28-32
23. Federico G, Tumbarello M, Spanu T, et al: Risk factors and prognostic indicators of bacterial meningitis in a cohort of 3580 postneurosurgical patients. Scand J Infect Dis 2001; 33:533-537
24. Javadekar BB, Vyas MD, Anand IS: CSF/blood glucose ratio and other prognostic indices in pyogenic meningitis. J Indian Med Assoc 1997; 95:9-11
25. Spinella PC, Dominguez T, Drott HR, et al: S-100B protein: Serum levels in healthy children and its association with outcome in pediatric traumatic brain injury. Crit Care Med 2003; 31:939-945
26. Raabe AGC, Sorge O, Zimmermann M, et al: Serum S-100b protein in severe head injury. Neurosurgery 1999; 45:477-482
27. Wunderlich MT, Ebert AD, Kratz T, et al: Early neurobehavioral outcome after stroke is related to release of neurobiochemical markers of brain damage. Stroke 1999; 30: 1190-1195
28. Rosen H, Rosengren L, Herlitz J, et al: Increased serum levels of the S-100 protein are associated with hypoxic brain damage after cardiac arrest. Stroke 1998; 29:473-477
29. Missler U, Wiesmann M, Friedrich C, et al: S-100 Protein and neuron-specific enolase concentrations in blood as indicators of infarction volume and prognosis in acute ischemic stroke. Stroke 1997; 28:1956-1960
30. Martens P, Raabe A, Johnsson P: Serum S-100 and neuron-specific enolase for prediction of regaining consciousness after global cerebral ischemia. Stroke 1998; 29: 2363-2366
31. Bottiger BW, Mobes S, Glatzer R, et al: Astroglial protein S-100 is an early and sensitive marker of hypoxic brain damage and outcome after cardiac arrest in humans. Circulation 2001; 103:2694-2698
32. de Gans J, van de Beek D, the European Dexamethasone in Adulthood Bacterial Meningitis Study Investigators: Dexamethasone in adults with bacterial meningitis. N Engl J Med 2002; 347:1549-1556
33. Mariggio MA, Fulle S, Calissano P, et al: The brain protein S100ab induces apoptosis in PC12 cells. Neuroscience 1994; 60:29-35
34. Fulle SPT, Mariggio MA, Lorenzon P, et al: Calcium and fos involvement in brainderived calcium-binding protein (S100)- dependent apoptosis in rat pheochromocytoma cells. Exp Physiol 2000; 85:243-253
35. Hu J FA, van Eldik LJ. S-100b induces neuronal cell death through nitric oxide release from astrocytes. J Neurochem 1997; 69: 2294-2301.